{"id": "article-143221_0", "title": "Cogan Syndrome -- Continuing Education Activity", "content": "Cogan syndrome is a rare multisystem autoimmune disease affecting the ocular and audiovestibular system with unknown pathogenesis. It occurs mainly in young white adults in the third decade of life as they present with interstitial keratitis and hearing loss. The autoimmune hypothesis is proposed due to the detection of different autoantibodies and the association with vasculitis, polyarteritis nodosa, and collagen vascular disease. Diagnosis requires a multidisciplinary approach based on audio-vestibular symptoms, ocular inflammation, and laboratory findings such as nonreactive serological tests for syphilis. This activity highlights the role of the interprofessional team in the management of patients with Conan syndrome.", "contents": "Cogan Syndrome -- Continuing Education Activity. Cogan syndrome is a rare multisystem autoimmune disease affecting the ocular and audiovestibular system with unknown pathogenesis. It occurs mainly in young white adults in the third decade of life as they present with interstitial keratitis and hearing loss. The autoimmune hypothesis is proposed due to the detection of different autoantibodies and the association with vasculitis, polyarteritis nodosa, and collagen vascular disease. Diagnosis requires a multidisciplinary approach based on audio-vestibular symptoms, ocular inflammation, and laboratory findings such as nonreactive serological tests for syphilis. This activity highlights the role of the interprofessional team in the management of patients with Conan syndrome."}
{"id": "article-143221_1", "title": "Cogan Syndrome -- Continuing Education Activity", "content": "Objectives: Describe the pathophysiology and histopathology of Cogan syndrome. Summarize the clinical evaluation of Cogan syndrome, including the differential diagnoses. Review the differential diagnoses of Cogan syndrome. Summarize the appropriate management of Cogan syndrome with prognosis. Access free multiple choice questions on this topic.", "contents": "Cogan Syndrome -- Continuing Education Activity. Objectives: Describe the pathophysiology and histopathology of Cogan syndrome. Summarize the clinical evaluation of Cogan syndrome, including the differential diagnoses. Review the differential diagnoses of Cogan syndrome. Summarize the appropriate management of Cogan syndrome with prognosis. Access free multiple choice questions on this topic."}
{"id": "article-143221_2", "title": "Cogan Syndrome -- Introduction", "content": "Cogan syndrome is an autoimmune disease characterized by inflammation of the inner ears and the eyes, presenting with vestibulo-auditory dysfunction and interstitial keratitis. [1] The disease progresses over 3 to 90 days\u00a0and usually shows a response to steroid treatment. [2]", "contents": "Cogan Syndrome -- Introduction. Cogan syndrome is an autoimmune disease characterized by inflammation of the inner ears and the eyes, presenting with vestibulo-auditory dysfunction and interstitial keratitis. [1] The disease progresses over 3 to 90 days\u00a0and usually shows a response to steroid treatment. [2]"}
{"id": "article-143221_3", "title": "Cogan Syndrome -- Introduction", "content": "Humoral and cellular immune responses are the suggested mechanisms. There is expression and upregulation of cytokines like intercellular cell adhesion molecule-1 (ICAM-1) and (IL-)1\u03b2. [3] Originally, Baumgartner and Morgan described the disease in 1934 as non-syphilitic interstitial keratitis with vestibular dysfunction. However,\u00a0Dr. David Cogan defined it as a clinical entity in 1945. [4]", "contents": "Cogan Syndrome -- Introduction. Humoral and cellular immune responses are the suggested mechanisms. There is expression and upregulation of cytokines like intercellular cell adhesion molecule-1 (ICAM-1) and (IL-)1\u03b2. [3] Originally, Baumgartner and Morgan described the disease in 1934 as non-syphilitic interstitial keratitis with vestibular dysfunction. However,\u00a0Dr. David Cogan defined it as a clinical entity in 1945. [4]"}
{"id": "article-143221_4", "title": "Cogan Syndrome -- Introduction", "content": "Cogan\u00a0syndrome is a diagnosis of exclusion, and other differentials, including syphilis, have to be ruled out before diagnosing Cogan\u00a0syndrome. Other features of Cogan\u00a0syndrome include fever, arthralgia, arthritis, headache, and myalgia. Vascular involvement, including aortitis, is an important manifestation of the disease. Cogan\u00a0syndrome is treated with corticosteroids and immunomodulatory therapy. Biologics and immunomodulatory therapy are promising therapies to improve the prognosis in such patients.", "contents": "Cogan Syndrome -- Introduction. Cogan\u00a0syndrome is a diagnosis of exclusion, and other differentials, including syphilis, have to be ruled out before diagnosing Cogan\u00a0syndrome. Other features of Cogan\u00a0syndrome include fever, arthralgia, arthritis, headache, and myalgia. Vascular involvement, including aortitis, is an important manifestation of the disease. Cogan\u00a0syndrome is treated with corticosteroids and immunomodulatory therapy. Biologics and immunomodulatory therapy are promising therapies to improve the prognosis in such patients."}
{"id": "article-143221_5", "title": "Cogan Syndrome -- Etiology", "content": "At first, Cogan\u00a0syndrome was believed to be a result of Chlamydia psittaci infection\u00a0because of remarkably elevated titers of antibodies to chlamydia trachomatis and the previous infection reported in a few patients. [5] The role of Chlamydia was not established by Vollertsen et al. [6]", "contents": "Cogan Syndrome -- Etiology. At first, Cogan\u00a0syndrome was believed to be a result of Chlamydia psittaci infection\u00a0because of remarkably elevated titers of antibodies to chlamydia trachomatis and the previous infection reported in a few patients. [5] The role of Chlamydia was not established by Vollertsen et al. [6]"}
{"id": "article-143221_6", "title": "Cogan Syndrome -- Etiology", "content": "Further literature on an infectious agent causing it has continued to stay negative, and antibiotic therapy has been unsuccessful. [4] Garcia Berrocal et al., in 1999, suggested that Cogan syndrome was due to hypersensitivity response to certain infectious agents, probably virus infection that provokes antibody response and cross-immunity with the proteins of the eye, audiovestibular system, and other organs. [7] Presently it is thought that Cogan syndrome is an autoimmune disease. However, no particular biomarker is present in the standard workup of Cogan syndrome. [4]", "contents": "Cogan Syndrome -- Etiology. Further literature on an infectious agent causing it has continued to stay negative, and antibiotic therapy has been unsuccessful. [4] Garcia Berrocal et al., in 1999, suggested that Cogan syndrome was due to hypersensitivity response to certain infectious agents, probably virus infection that provokes antibody response and cross-immunity with the proteins of the eye, audiovestibular system, and other organs. [7] Presently it is thought that Cogan syndrome is an autoimmune disease. However, no particular biomarker is present in the standard workup of Cogan syndrome. [4]"}
{"id": "article-143221_7", "title": "Cogan Syndrome -- Epidemiology", "content": "Cogan syndrome is a rare disorder, with around 250 cases announced so far. [4] It occurs mainly in young White race adults in the third decade of life. [8] The mean age of onset is 25 years, with a range of 5 to 63 years. [9] No gender\u00a0predominance\u00a0seemed to occur in the reported cases. [10]", "contents": "Cogan Syndrome -- Epidemiology. Cogan syndrome is a rare disorder, with around 250 cases announced so far. [4] It occurs mainly in young White race adults in the third decade of life. [8] The mean age of onset is 25 years, with a range of 5 to 63 years. [9] No gender\u00a0predominance\u00a0seemed to occur in the reported cases. [10]"}
{"id": "article-143221_8", "title": "Cogan Syndrome -- Epidemiology", "content": "It is an exceedingly rare disorder in Middle Eastern countries. However, the first case was reported in Jordan in 2012. [4] The number of cases could be more than reported as many may be falsely diagnosed as idiopathic keratitis and idiopathic hearing loss or deafness. [11]", "contents": "Cogan Syndrome -- Epidemiology. It is an exceedingly rare disorder in Middle Eastern countries. However, the first case was reported in Jordan in 2012. [4] The number of cases could be more than reported as many may be falsely diagnosed as idiopathic keratitis and idiopathic hearing loss or deafness. [11]"}
{"id": "article-143221_9", "title": "Cogan Syndrome -- Pathophysiology", "content": "Cogan syndrome is believed to be an autoimmune disease due to the detection of different autoantibodies and associated vasculitis, polyarteritis nodosa, and collagen vascular disease. [4] Furthermore, the antibodies against the Cogan peptide demonstrated a cross-reaction with Reovirus type III structural protein, proposing the involvement of a virus through a molecular mimicry mechanism. This suggests similarities between foreign and self-peptides resulting in the cross-activation of the cells by the peptides. [12]", "contents": "Cogan Syndrome -- Pathophysiology. Cogan syndrome is believed to be an autoimmune disease due to the detection of different autoantibodies and associated vasculitis, polyarteritis nodosa, and collagen vascular disease. [4] Furthermore, the antibodies against the Cogan peptide demonstrated a cross-reaction with Reovirus type III structural protein, proposing the involvement of a virus through a molecular mimicry mechanism. This suggests similarities between foreign and self-peptides resulting in the cross-activation of the cells by the peptides. [12]"}
{"id": "article-143221_10", "title": "Cogan Syndrome -- Pathophysiology", "content": "Molecular mimicry is one of the mechanisms through which autoimmunity can arise. This happens when the exogenous agents such as bacteria, viruses, and others and human normal host-cell components share the antigenic determinants. [12] However, before the onset of Cogan syndrome, infection with Reovirus type III causing upper respiratory infections, pharyngitis, and mild rhinitis are frequently observed. [9]", "contents": "Cogan Syndrome -- Pathophysiology. Molecular mimicry is one of the mechanisms through which autoimmunity can arise. This happens when the exogenous agents such as bacteria, viruses, and others and human normal host-cell components share the antigenic determinants. [12] However, before the onset of Cogan syndrome, infection with Reovirus type III causing upper respiratory infections, pharyngitis, and mild rhinitis are frequently observed. [9]"}
{"id": "article-143221_11", "title": "Cogan Syndrome -- Pathophysiology", "content": "A study was done in 2002 in which a peptide called Cogan peptide was discovered in 8 patients. The peptide was like reovirus III major core protein lambda and SSA/Ro. [12] Recently, anti-neutrophil cytoplasmic autoantibodies (ANCA) were discovered in 5 patients, and a few cases showed ANCA-related glomerulonephritis. [13]", "contents": "Cogan Syndrome -- Pathophysiology. A study was done in 2002 in which a peptide called Cogan peptide was discovered in 8 patients. The peptide was like reovirus III major core protein lambda and SSA/Ro. [12] Recently, anti-neutrophil cytoplasmic autoantibodies (ANCA) were discovered in 5 patients, and a few cases showed ANCA-related glomerulonephritis. [13]"}
{"id": "article-143221_12", "title": "Cogan Syndrome -- Histopathology", "content": "A histopathologic examination of corneal tissue and cochlea by multiple groups showed plasma cells and lymphocytes infiltration, indicating a cell-mediated reaction that\u00a0may explain the audiovestibular dysfunction, which includes severe vertigo, bilateral fluctuating hearing loss, and tinnitus. [14]", "contents": "Cogan Syndrome -- Histopathology. A histopathologic examination of corneal tissue and cochlea by multiple groups showed plasma cells and lymphocytes infiltration, indicating a cell-mediated reaction that\u00a0may explain the audiovestibular dysfunction, which includes severe vertigo, bilateral fluctuating hearing loss, and tinnitus. [14]"}
{"id": "article-143221_13", "title": "Cogan Syndrome -- Histopathology", "content": "In addition to cochlear neuron loss, endolymphatic hydrops, new bone formation, degenerative changes in the organ of Corti, and atrophy and demyelination of vestibulocochlear cranial nerve may be noted. [15] [16]", "contents": "Cogan Syndrome -- Histopathology. In addition to cochlear neuron loss, endolymphatic hydrops, new bone formation, degenerative changes in the organ of Corti, and atrophy and demyelination of vestibulocochlear cranial nerve may be noted. [15] [16]"}
{"id": "article-143221_14", "title": "Cogan Syndrome -- Histopathology", "content": "Further\u00a0pathologic findings that are nonspecific yet compatible with a chronic inflammatory process\u00a0include damaged aortic valves in aortitis,\u00a0aortic valve\u00a0cusp detachments and outpouchings, thinning or thickening, fenestrations, and retraction. [17] [18] Microscopically, lymphoid cell infiltration, myxomatous changes, and fibrinoid necrosis were revealed in the affected valves. [19] [20] [21]", "contents": "Cogan Syndrome -- Histopathology. Further\u00a0pathologic findings that are nonspecific yet compatible with a chronic inflammatory process\u00a0include damaged aortic valves in aortitis,\u00a0aortic valve\u00a0cusp detachments and outpouchings, thinning or thickening, fenestrations, and retraction. [17] [18] Microscopically, lymphoid cell infiltration, myxomatous changes, and fibrinoid necrosis were revealed in the affected valves. [19] [20] [21]"}
{"id": "article-143221_15", "title": "Cogan Syndrome -- History and Physical", "content": "Haynes and co-authors brought up a classification of Cogan syndrome in 1980 as typical (defined by Cogan) and atypical (structures other than cornea are involved, such as uvea, conjunctiva, sclera, optic disc, and retinal vessels). [22] Typical or classic Cogan syndrome is characterized by:", "contents": "Cogan Syndrome -- History and Physical. Haynes and co-authors brought up a classification of Cogan syndrome in 1980 as typical (defined by Cogan) and atypical (structures other than cornea are involved, such as uvea, conjunctiva, sclera, optic disc, and retinal vessels). [22] Typical or classic Cogan syndrome is characterized by:"}
{"id": "article-143221_16", "title": "Cogan Syndrome -- History and Physical", "content": "1- non-syphilitic interstitial keratitis (IK) with possible iritis, subconjunctival/conjunctival hemorrhage, lacrimation, and red-eye. The keratitis begins in the subepithelial region and rapidly evolves into interstitial keratitis that usually develops corneal neovascularization. Interstitial keratitis is the most common ocular feature of Cogan syndrome. One or both eyes can be involved. Usually, the visual prognosis is good. The interstitial keratitis progresses rapidly and then resolves, usually with corneal scarring and ghost vessels. The symptoms of active IK include redness, sensitivity to light (photophobia), visual decline, ocular pain, and watering. There may be recurrences of these symptoms years after initial resolution.", "contents": "Cogan Syndrome -- History and Physical. 1- non-syphilitic interstitial keratitis (IK) with possible iritis, subconjunctival/conjunctival hemorrhage, lacrimation, and red-eye. The keratitis begins in the subepithelial region and rapidly evolves into interstitial keratitis that usually develops corneal neovascularization. Interstitial keratitis is the most common ocular feature of Cogan syndrome. One or both eyes can be involved. Usually, the visual prognosis is good. The interstitial keratitis progresses rapidly and then resolves, usually with corneal scarring and ghost vessels. The symptoms of active IK include redness, sensitivity to light (photophobia), visual decline, ocular pain, and watering. There may be recurrences of these symptoms years after initial resolution."}
{"id": "article-143221_17", "title": "Cogan Syndrome -- History and Physical", "content": "2- vestibular association similar to M\u00e9ni\u00e8re disease, with gradual hearing loss that might lead to deafness occurring within two years from the eye symptoms.\u00a0The\u00a0sensorineural hearing loss\u00a0usually aggravates rapidly, usually leading to deafness in 1\u00a0to 3 months. In typical Cogan syndrome, the vestibulo-auditory symptoms arise within two years of ocular involvement. [5]", "contents": "Cogan Syndrome -- History and Physical. 2- vestibular association similar to M\u00e9ni\u00e8re disease, with gradual hearing loss that might lead to deafness occurring within two years from the eye symptoms.\u00a0The\u00a0sensorineural hearing loss\u00a0usually aggravates rapidly, usually leading to deafness in 1\u00a0to 3 months. In typical Cogan syndrome, the vestibulo-auditory symptoms arise within two years of ocular involvement. [5]"}
{"id": "article-143221_18", "title": "Cogan Syndrome -- History and Physical", "content": "In contrast, atypical Cogan syndrome is when 1. other types of ocular involvement are present such as conjunctivitis, scleritis, choroiditis, episcleritis, uveitis, closed-angle glaucoma, retinal vasculitis, retinal hemorrhages, retinal artery occlusion, central retinal vein occlusion, exophthalmos, vasculitis optic neuropathy, papillitis, or optic disc edema, 2. audiovestibular symptoms do not resemble M\u00e9ni\u00e8re disease or appear before or after ocular symptoms for more than two years. [7] Systemic features are more common in atypical Cogan syndrome. However, patients with typical Cogan syndrome may develop features of atypical Cogan syndrome later. [23]", "contents": "Cogan Syndrome -- History and Physical. In contrast, atypical Cogan syndrome is when 1. other types of ocular involvement are present such as conjunctivitis, scleritis, choroiditis, episcleritis, uveitis, closed-angle glaucoma, retinal vasculitis, retinal hemorrhages, retinal artery occlusion, central retinal vein occlusion, exophthalmos, vasculitis optic neuropathy, papillitis, or optic disc edema, 2. audiovestibular symptoms do not resemble M\u00e9ni\u00e8re disease or appear before or after ocular symptoms for more than two years. [7] Systemic features are more common in atypical Cogan syndrome. However, patients with typical Cogan syndrome may develop features of atypical Cogan syndrome later. [23]"}
{"id": "article-143221_19", "title": "Cogan Syndrome -- History and Physical", "content": "Cogan syndrome follows an upper respiratory tract infection (URTI) episode in almost 27% of reported cases. A history of diarrhea, immunization or dental infections may be present.\u00a0Mostly, the ears or the eyes alone are firstly affected. The most common ocular involvement is interstitial keratitis and other presentations: retinal vascular disease, scleritis, uveitis, episcleritis, papilledema, exophthalmos, conjunctivitis, and tendonitis.\u00a0Seventy-four percent of patients present with ocular redness, 50% with pain, 50% with photophobia and tearing, and 42% with diminished visual acuity.", "contents": "Cogan Syndrome -- History and Physical. Cogan syndrome follows an upper respiratory tract infection (URTI) episode in almost 27% of reported cases. A history of diarrhea, immunization or dental infections may be present.\u00a0Mostly, the ears or the eyes alone are firstly affected. The most common ocular involvement is interstitial keratitis and other presentations: retinal vascular disease, scleritis, uveitis, episcleritis, papilledema, exophthalmos, conjunctivitis, and tendonitis.\u00a0Seventy-four percent of patients present with ocular redness, 50% with pain, 50% with photophobia and tearing, and 42% with diminished visual acuity."}
{"id": "article-143221_20", "title": "Cogan Syndrome -- History and Physical", "content": "Examination shows ciliary injection associated with iritis, opacities in the corneal stroma, and a granular corneal infiltration, especially in the posterior portion of the cornea close to the limbus.\u00a0Secondary corneal neovascularization usually occurs. Both eyes are involved\u00a0in most patients. However, the symptoms may differ\u00a0in each eye. Some patients may present with blindness or amaurosis. [24]", "contents": "Cogan Syndrome -- History and Physical. Examination shows ciliary injection associated with iritis, opacities in the corneal stroma, and a granular corneal infiltration, especially in the posterior portion of the cornea close to the limbus.\u00a0Secondary corneal neovascularization usually occurs. Both eyes are involved\u00a0in most patients. However, the symptoms may differ\u00a0in each eye. Some patients may present with blindness or amaurosis. [24]"}
{"id": "article-143221_21", "title": "Cogan Syndrome -- History and Physical", "content": "Multiple\u00a0organs are affected in\u00a02/3rd of\u00a0cases, and another systemic disorder was seen in 1/3rd of the cases.\u00a0Interstitial keratitis may not be the presenting feature and may develop years later.\u00a0There may be sectoral conjunctival congestion with subepithelial/anterior corneal stromal peripheral or mid-peripheral keratitis.", "contents": "Cogan Syndrome -- History and Physical. Multiple\u00a0organs are affected in\u00a02/3rd of\u00a0cases, and another systemic disorder was seen in 1/3rd of the cases.\u00a0Interstitial keratitis may not be the presenting feature and may develop years later.\u00a0There may be sectoral conjunctival congestion with subepithelial/anterior corneal stromal peripheral or mid-peripheral keratitis."}
{"id": "article-143221_22", "title": "Cogan Syndrome -- History and Physical", "content": "The first system affected is the vestibular system, followed by the cochlear system in days or weeks.\u00a0The symptoms are similar to recurrent M\u00e9ni\u00e8re disease, including nausea, vomiting, vertigo, and tinnitus. Progressive sensory hearing loss is noted that causes deafness in 1-3 months.\u00a0Spontaneous nystagmus and a degree of ataxia can occur.\u00a0A study by Grasland et al.\u00a0showed that\u00a0the disease affects both the ocular and audiovestibular system\u00a0in 17/52 (33%) patients with typical Cogan syndrome compared to atypical Cogan syndrome (12% of patients). [24]", "contents": "Cogan Syndrome -- History and Physical. The first system affected is the vestibular system, followed by the cochlear system in days or weeks.\u00a0The symptoms are similar to recurrent M\u00e9ni\u00e8re disease, including nausea, vomiting, vertigo, and tinnitus. Progressive sensory hearing loss is noted that causes deafness in 1-3 months.\u00a0Spontaneous nystagmus and a degree of ataxia can occur.\u00a0A study by Grasland et al.\u00a0showed that\u00a0the disease affects both the ocular and audiovestibular system\u00a0in 17/52 (33%) patients with typical Cogan syndrome compared to atypical Cogan syndrome (12% of patients). [24]"}
{"id": "article-143221_23", "title": "Cogan Syndrome -- History and Physical", "content": "Systemic involvement is present in around 30 to 80% of patients.\u00a0Cardiovascular manifestations typically involve aortitis,\u00a0which leads to aortic insufficiency in around 10% of patients and congestive heart failure. [25]", "contents": "Cogan Syndrome -- History and Physical. Systemic involvement is present in around 30 to 80% of patients.\u00a0Cardiovascular manifestations typically involve aortitis,\u00a0which leads to aortic insufficiency in around 10% of patients and congestive heart failure. [25]"}
{"id": "article-143221_24", "title": "Cogan Syndrome -- History and Physical", "content": "Neurologic symptoms are nonspecific, including headache and coma.\u00a0Some rare manifestations such as pyramidal syndrome, spinal cord disease, cerebellar syndrome, meningeal syndrome, peripheral neuropathy, facial palsy, and encephalitis may occur. [24]", "contents": "Cogan Syndrome -- History and Physical. Neurologic symptoms are nonspecific, including headache and coma.\u00a0Some rare manifestations such as pyramidal syndrome, spinal cord disease, cerebellar syndrome, meningeal syndrome, peripheral neuropathy, facial palsy, and encephalitis may occur. [24]"}
{"id": "article-143221_25", "title": "Cogan Syndrome -- History and Physical", "content": "Musculoskeletal manifestations may occur, including arthritis, myalgias, synovitis, arthralgia, and articular effusion. Results of muscle biopsies may\u00a0be abnormal and show atrophy and muscle necrosis and may mimic myositis.\u00a0The rest of the systemic manifestations are quite rare\u00a0such as cutaneous signs (urticarial rash, erythematous rash, nodules, ulcerations, vascular purpura), lung involvement (dyspnea, cough, pleurisy, hemoptysis, thoracic pain, discrete\u00a0abnormalities on radiological images), urinalysis abnormalities, and lymphadenopathies. [26]", "contents": "Cogan Syndrome -- History and Physical. Musculoskeletal manifestations may occur, including arthritis, myalgias, synovitis, arthralgia, and articular effusion. Results of muscle biopsies may\u00a0be abnormal and show atrophy and muscle necrosis and may mimic myositis.\u00a0The rest of the systemic manifestations are quite rare\u00a0such as cutaneous signs (urticarial rash, erythematous rash, nodules, ulcerations, vascular purpura), lung involvement (dyspnea, cough, pleurisy, hemoptysis, thoracic pain, discrete\u00a0abnormalities on radiological images), urinalysis abnormalities, and lymphadenopathies. [26]"}
{"id": "article-143221_26", "title": "Cogan Syndrome -- Evaluation", "content": "Unfortunately, there is no particular marker for Cogan syndrome. However, some\u00a0labs can be abnormal. Differential diagnoses must be ruled out by extensive investigations as Cogan syndrome is a diagnosis of exclusion. The usual findings are anemia, leukocytosis, thrombocytosis, and elevated ESR (erythrocyte sedimentation rate) along with hypofibrinogenemia and high CRP (c-reactive protein) during acute attacks.\u00a0In some cases, antibodies against Chlamydia\u00a0trachomatis or Chlamydia psittaci may be discovered. However,\u00a0other features of\u00a0infections may be absent. [24]", "contents": "Cogan Syndrome -- Evaluation. Unfortunately, there is no particular marker for Cogan syndrome. However, some\u00a0labs can be abnormal. Differential diagnoses must be ruled out by extensive investigations as Cogan syndrome is a diagnosis of exclusion. The usual findings are anemia, leukocytosis, thrombocytosis, and elevated ESR (erythrocyte sedimentation rate) along with hypofibrinogenemia and high CRP (c-reactive protein) during acute attacks.\u00a0In some cases, antibodies against Chlamydia\u00a0trachomatis or Chlamydia psittaci may be discovered. However,\u00a0other features of\u00a0infections may be absent. [24]"}
{"id": "article-143221_27", "title": "Cogan Syndrome -- Evaluation", "content": "On urinalysis, proteinuria and hematuria\u00a0may be present. Certain antibodies\u00a0may be present, including antinuclear antibodies (ANA), antibodies to smooth muscle, lupus anticoagulants, cryoglobulins, anti-neutrophil cytoplasmic autoantibodies (ANCA), or rheumatoid factor (RF). In some cases, direct antibodies were detected against components of the inner ear and corneal antigen. [24]", "contents": "Cogan Syndrome -- Evaluation. On urinalysis, proteinuria and hematuria\u00a0may be present. Certain antibodies\u00a0may be present, including antinuclear antibodies (ANA), antibodies to smooth muscle, lupus anticoagulants, cryoglobulins, anti-neutrophil cytoplasmic autoantibodies (ANCA), or rheumatoid factor (RF). In some cases, direct antibodies were detected against components of the inner ear and corneal antigen. [24]"}
{"id": "article-143221_28", "title": "Cogan Syndrome -- Evaluation", "content": "Antibodies against heat shock protein may be present in around half of the patients with Cogan syndrome. Audiometry shows sensorineural hearing loss of all frequencies.\u00a0Word recognition ability might improve or deteriorate; the initial evaluation demonstrates sensory hearing loss with abnormal electronystagmography. [27]", "contents": "Cogan Syndrome -- Evaluation. Antibodies against heat shock protein may be present in around half of the patients with Cogan syndrome. Audiometry shows sensorineural hearing loss of all frequencies.\u00a0Word recognition ability might improve or deteriorate; the initial evaluation demonstrates sensory hearing loss with abnormal electronystagmography. [27]"}
{"id": "article-143221_29", "title": "Cogan Syndrome -- Treatment / Management", "content": "Treatment of Cogan syndrome depends on its severity, whether it\u00a0is limited to ocular disease or extensive inner ear, ocular or systemic vasculitis. High-dose corticosteroids (1\u00a0to 2 mg/kg/day) for systemic vasculitis are the first line to obtain remission. [28]", "contents": "Cogan Syndrome -- Treatment / Management. Treatment of Cogan syndrome depends on its severity, whether it\u00a0is limited to ocular disease or extensive inner ear, ocular or systemic vasculitis. High-dose corticosteroids (1\u00a0to 2 mg/kg/day) for systemic vasculitis are the first line to obtain remission. [28]"}
{"id": "article-143221_30", "title": "Cogan Syndrome -- Treatment / Management", "content": "If an improvement occurs, corticosteroids\u00a0may be tapered over 2\u00a0to 6 months. The corticosteroid should be discontinued if no response occurs.\u00a0Failure of treatment will require additional immunosuppressive therapy like methotrexate, azathioprine, cyclophosphamide, and cyclosporine A, which have shown better outcomes. [29] [30] Interstitial keratitis is treated with topical steroids and cycloplegics, systemic steroids,\u00a0disease-modifying anti-rheumatic drugs (DMARDs), and biologics.", "contents": "Cogan Syndrome -- Treatment / Management. If an improvement occurs, corticosteroids\u00a0may be tapered over 2\u00a0to 6 months. The corticosteroid should be discontinued if no response occurs.\u00a0Failure of treatment will require additional immunosuppressive therapy like methotrexate, azathioprine, cyclophosphamide, and cyclosporine A, which have shown better outcomes. [29] [30] Interstitial keratitis is treated with topical steroids and cycloplegics, systemic steroids,\u00a0disease-modifying anti-rheumatic drugs (DMARDs), and biologics."}
{"id": "article-143221_31", "title": "Cogan Syndrome -- Treatment / Management", "content": "The early treatment with systemic corticosteroids determines the course of audiovestibular involvement. However, corticosteroid eye drops or local atropine can be used for interstitial keratitis, which shows a good response. Cogan syndrome with large vessel vasculitis\u00a0has also been treated with oral cyclophosphamide (starting at 2 to 3 mg/kg/day)\u00a0given for four to six months.\u00a0If no response to cyclophosphamide is noted, cyclosporine (4 mg/kg/day or less) may be used. [30]", "contents": "Cogan Syndrome -- Treatment / Management. The early treatment with systemic corticosteroids determines the course of audiovestibular involvement. However, corticosteroid eye drops or local atropine can be used for interstitial keratitis, which shows a good response. Cogan syndrome with large vessel vasculitis\u00a0has also been treated with oral cyclophosphamide (starting at 2 to 3 mg/kg/day)\u00a0given for four to six months.\u00a0If no response to cyclophosphamide is noted, cyclosporine (4 mg/kg/day or less) may be used. [30]"}
{"id": "article-143221_32", "title": "Cogan Syndrome -- Treatment / Management", "content": "Tumor necrosis factors (TNF-a) inhibitory agents have recently been another therapeutic option, with infliximab, a chimeric anti-TNF-a monoclonal antibody being the most effective, according to a recent literature review that showed 11 out of 12 cases treated with infliximab have achieved clinical remission. [31] [32]", "contents": "Cogan Syndrome -- Treatment / Management. Tumor necrosis factors (TNF-a) inhibitory agents have recently been another therapeutic option, with infliximab, a chimeric anti-TNF-a monoclonal antibody being the most effective, according to a recent literature review that showed 11 out of 12 cases treated with infliximab have achieved clinical remission. [31] [32]"}
{"id": "article-143221_33", "title": "Cogan Syndrome -- Treatment / Management", "content": "Rituximab has been shown to\u00a0reduce the medications used to control the systemic manifestations and help avoid cochlear implants or deafness in certain severe cases; however, it is not used as a first-line. [33] For those who did not respond to pharmacologic therapy for hearing loss, cochlear implants have been beneficial. [34] [35]", "contents": "Cogan Syndrome -- Treatment / Management. Rituximab has been shown to\u00a0reduce the medications used to control the systemic manifestations and help avoid cochlear implants or deafness in certain severe cases; however, it is not used as a first-line. [33] For those who did not respond to pharmacologic therapy for hearing loss, cochlear implants have been beneficial. [34] [35]"}
{"id": "article-143221_34", "title": "Cogan Syndrome -- Treatment / Management", "content": "Benzodiazepines, antihistamines, or vestibular therapy can be used for chronic vestibular dysfunction that occurs in a few cases. [36] A fast-growing interest in stem-cell-based treatment has developed for autoimmune disorders; however, additional studies are required to\u00a0confirm the long-term safety and efficacy. [37]", "contents": "Cogan Syndrome -- Treatment / Management. Benzodiazepines, antihistamines, or vestibular therapy can be used for chronic vestibular dysfunction that occurs in a few cases. [36] A fast-growing interest in stem-cell-based treatment has developed for autoimmune disorders; however, additional studies are required to\u00a0confirm the long-term safety and efficacy. [37]"}
{"id": "article-143221_35", "title": "Cogan Syndrome -- Differential Diagnosis", "content": "Various diseases have been included in the differential diagnosis of Cogan syndrome due to the audiovestibular and ocular associations such as these:", "contents": "Cogan Syndrome -- Differential Diagnosis. Various diseases have been included in the differential diagnosis of Cogan syndrome due to the audiovestibular and ocular associations such as these:"}
{"id": "article-143221_36", "title": "Cogan Syndrome -- Differential Diagnosis", "content": "Susac syndrome (retinocochleocerberal vasculopathy or SICRET syndrome-small infarctions of cochlear, retinal, and encephalic tissue):\u00a0Susac syndrome is characterized by lesions of the cochlear, retinal, and cerebral arterioles. [4]", "contents": "Cogan Syndrome -- Differential Diagnosis. Susac syndrome (retinocochleocerberal vasculopathy or SICRET syndrome-small infarctions of cochlear, retinal, and encephalic tissue):\u00a0Susac syndrome is characterized by lesions of the cochlear, retinal, and cerebral arterioles. [4]"}
{"id": "article-143221_37", "title": "Cogan Syndrome -- Differential Diagnosis", "content": "Congenital syphilis: The Hutchinson triad of congenital syphilis includes Hutchinson teeth (notched peg-shaped upper incisors), interstitial keratitis, and sensorineural hearing loss. [38] Serology for syphilis\u00a0must be negative for making a diagnosis of Cogan syndrome.", "contents": "Cogan Syndrome -- Differential Diagnosis. Congenital syphilis: The Hutchinson triad of congenital syphilis includes Hutchinson teeth (notched peg-shaped upper incisors), interstitial keratitis, and sensorineural hearing loss. [38] Serology for syphilis\u00a0must be negative for making a diagnosis of Cogan syndrome."}
{"id": "article-143221_38", "title": "Cogan Syndrome -- Differential Diagnosis", "content": "The association of necrotizing vasculitis after acute serous otitis media and acute episcleritis described\u00a0by Sergent and Christian in 1994 (with no inner ear involvement)", "contents": "Cogan Syndrome -- Differential Diagnosis. The association of necrotizing vasculitis after acute serous otitis media and acute episcleritis described\u00a0by Sergent and Christian in 1994 (with no inner ear involvement)"}
{"id": "article-143221_39", "title": "Cogan Syndrome -- Differential Diagnosis", "content": "Vogt-Koyanagi-Harada syndrome:\u00a0Vogt-Koyanagi-Harada syndrome is identified by diminished visual acuity, sensorineural hearing loss, and uveoencephalitis with meningism (which sometimes occurs in Cogan syndrome), poliosis, and alopecia.\u00a0Meningism may occur in patients with Cogan syndrome. However, alopecia and poliosis do not. [26]", "contents": "Cogan Syndrome -- Differential Diagnosis. Vogt-Koyanagi-Harada syndrome:\u00a0Vogt-Koyanagi-Harada syndrome is identified by diminished visual acuity, sensorineural hearing loss, and uveoencephalitis with meningism (which sometimes occurs in Cogan syndrome), poliosis, and alopecia.\u00a0Meningism may occur in patients with Cogan syndrome. However, alopecia and poliosis do not. [26]"}
{"id": "article-143221_40", "title": "Cogan Syndrome -- Differential Diagnosis", "content": "Polyarteritis nodosa", "contents": "Cogan Syndrome -- Differential Diagnosis. Polyarteritis nodosa"}
{"id": "article-143221_41", "title": "Cogan Syndrome -- Differential Diagnosis", "content": "Granulomatosis with polyangiitis: Granulomatosis with polyangiitis often involves the ear and eye. Vasculitic changes involving small vessels, pulmonary infiltrates, glomerulonephritis, hemorrhagic lesions of the nose and throat, and the presence of c-ANCA (cytoplasmic ANCA) are usually seen in patients with granulomatosis with polyangiitis (previously called Wegner granulomatosis). Cogan syndrome patients do not fulfill these criteria.", "contents": "Cogan Syndrome -- Differential Diagnosis. Granulomatosis with polyangiitis: Granulomatosis with polyangiitis often involves the ear and eye. Vasculitic changes involving small vessels, pulmonary infiltrates, glomerulonephritis, hemorrhagic lesions of the nose and throat, and the presence of c-ANCA (cytoplasmic ANCA) are usually seen in patients with granulomatosis with polyangiitis (previously called Wegner granulomatosis). Cogan syndrome patients do not fulfill these criteria."}
{"id": "article-143221_42", "title": "Cogan Syndrome -- Differential Diagnosis", "content": "Takayasu arteritis [11]", "contents": "Cogan Syndrome -- Differential Diagnosis. Takayasu arteritis [11]"}
{"id": "article-143221_43", "title": "Cogan Syndrome -- Differential Diagnosis", "content": "It is challenging to diagnose Cogan syndrome during the early stages of the disease.\u00a0However, the coexistence between Cogan syndrome and other autoimmune disorders has been revealed by a literature review, such as the presence of Cogan syndrome with rheumatoid arthritis,\u00a0granulomatosis with polyangiitis,\u00a0and tubulointerstitial nephritis, and uveitis (TINU syndrome). [39]", "contents": "Cogan Syndrome -- Differential Diagnosis. It is challenging to diagnose Cogan syndrome during the early stages of the disease.\u00a0However, the coexistence between Cogan syndrome and other autoimmune disorders has been revealed by a literature review, such as the presence of Cogan syndrome with rheumatoid arthritis,\u00a0granulomatosis with polyangiitis,\u00a0and tubulointerstitial nephritis, and uveitis (TINU syndrome). [39]"}
{"id": "article-143221_44", "title": "Cogan Syndrome -- Differential Diagnosis", "content": "A study showed that four patients with inflammatory bowel disease (IBD) presented with Cogan syndrome, ocular inflammation, and sensorineural hearing loss (SNHL) after the GI (gastrointestinal) symptoms. [40] A large international multicenter study reported 22 CS-IBD patients; half of them had Cogan syndrome onset after the GI symptoms. [41]", "contents": "Cogan Syndrome -- Differential Diagnosis. A study showed that four patients with inflammatory bowel disease (IBD) presented with Cogan syndrome, ocular inflammation, and sensorineural hearing loss (SNHL) after the GI (gastrointestinal) symptoms. [40] A large international multicenter study reported 22 CS-IBD patients; half of them had Cogan syndrome onset after the GI symptoms. [41]"}
{"id": "article-143221_45", "title": "Cogan Syndrome -- Differential Diagnosis", "content": "Differential diagnoses of interstitial keratitis include\u00a0syphilis, chlamydia, leprosy, tuberculosis, brucellosis, leptospirosis, Lyme disease, herpes, measles, mumps, pox, parasitic infestation (onchocerciasis),\u00a0and autoimmune diseases (rheumatoid arthritis, sarcoidosis, granulomatosis with polyangiitis). [42]", "contents": "Cogan Syndrome -- Differential Diagnosis. Differential diagnoses of interstitial keratitis include\u00a0syphilis, chlamydia, leprosy, tuberculosis, brucellosis, leptospirosis, Lyme disease, herpes, measles, mumps, pox, parasitic infestation (onchocerciasis),\u00a0and autoimmune diseases (rheumatoid arthritis, sarcoidosis, granulomatosis with polyangiitis). [42]"}
{"id": "article-143221_46", "title": "Cogan Syndrome -- Prognosis", "content": "The prognosis for Cogan syndrome is generally poor when ear, eye, and cardiovascular involvement occur. In contrast to corneal disease, ear disease has a poor prognosis in the long term as deafness will be irreversible. [26]", "contents": "Cogan Syndrome -- Prognosis. The prognosis for Cogan syndrome is generally poor when ear, eye, and cardiovascular involvement occur. In contrast to corneal disease, ear disease has a poor prognosis in the long term as deafness will be irreversible. [26]"}
{"id": "article-143221_47", "title": "Cogan Syndrome -- Prognosis", "content": "Complete hearing loss was noted in one ear in 18 percent and both ears in 52 percent of 60 patients who received care at Mayo clinic between 1940\u00a0and 2002. At the final follow-up, most patients had normal or near-normal eyesight in this study.\u00a0A\u00a0retrospective study\u00a0on Cogan syndrome from France showed higher relapse rates from patients at Mayo clinic (78% during 7.1 years of follow-up) than relapse rates (13 and 31 percent of patients relapsed at 5 and 10 years, respectively). [43]", "contents": "Cogan Syndrome -- Prognosis. Complete hearing loss was noted in one ear in 18 percent and both ears in 52 percent of 60 patients who received care at Mayo clinic between 1940\u00a0and 2002. At the final follow-up, most patients had normal or near-normal eyesight in this study.\u00a0A\u00a0retrospective study\u00a0on Cogan syndrome from France showed higher relapse rates from patients at Mayo clinic (78% during 7.1 years of follow-up) than relapse rates (13 and 31 percent of patients relapsed at 5 and 10 years, respectively). [43]"}
{"id": "article-143221_48", "title": "Cogan Syndrome -- Prognosis", "content": "Both groups were uniformly treated with high doses of glucocorticoids.\u00a0However, the patients from the French study had\u00a0more use of immunosuppressive agents than those managed at the Mayo Clinic. In the French study, ten patients were treated with infliximab which was only approved in late 1998.\u00a0Deterioration of auditory performance after cochlear implants have been noticed by Bovo et al. due to the progression of new bone in the cochlea, which separates the electrode from neural structures. [44] [45]", "contents": "Cogan Syndrome -- Prognosis. Both groups were uniformly treated with high doses of glucocorticoids.\u00a0However, the patients from the French study had\u00a0more use of immunosuppressive agents than those managed at the Mayo Clinic. In the French study, ten patients were treated with infliximab which was only approved in late 1998.\u00a0Deterioration of auditory performance after cochlear implants have been noticed by Bovo et al. due to the progression of new bone in the cochlea, which separates the electrode from neural structures. [44] [45]"}
{"id": "article-143221_49", "title": "Cogan Syndrome -- Complications", "content": "Systemic vasculitis, usually involving large and/or medium vessels, has been reported in 15\u00a0to 21% of cases. However, vessels of any size may be affected. [46] Life-threatening complications were reported in 10% of cases like aortic insufficiency, aneurysms, and dissection. [47] Other valves were involved\u00a0leading to complications including\u00a0mitral insufficiency. [48]", "contents": "Cogan Syndrome -- Complications. Systemic vasculitis, usually involving large and/or medium vessels, has been reported in 15\u00a0to 21% of cases. However, vessels of any size may be affected. [46] Life-threatening complications were reported in 10% of cases like aortic insufficiency, aneurysms, and dissection. [47] Other valves were involved\u00a0leading to complications including\u00a0mitral insufficiency. [48]"}
{"id": "article-143221_50", "title": "Cogan Syndrome -- Complications", "content": "Organs that may be affected by systemic vasculitis\u00a0include the brain and kidneys, as the stroke was seen in some Cogan syndrome patients. [49] Neurological symptoms include aphasia due to TIA (transient ischemic attack), hemiplegia, and hemiparesis\u00a0due to a cerebral vascular accident.", "contents": "Cogan Syndrome -- Complications. Organs that may be affected by systemic vasculitis\u00a0include the brain and kidneys, as the stroke was seen in some Cogan syndrome patients. [49] Neurological symptoms include aphasia due to TIA (transient ischemic attack), hemiplegia, and hemiparesis\u00a0due to a cerebral vascular accident."}
{"id": "article-143221_51", "title": "Cogan Syndrome -- Deterrence and Patient Education", "content": "Cogan syndrome is a rare autoimmune disorder that presents with audiovestibular symptoms and non-syphilitic interstitial keratitis. The beneficial response to corticosteroids supports autoimmune pathogenesis. However, the treatment is sometimes difficult as failure to treat hearing loss may cause deafness. Permanent hearing loss usually occurs due to recurrent flares. [50]", "contents": "Cogan Syndrome -- Deterrence and Patient Education. Cogan syndrome is a rare autoimmune disorder that presents with audiovestibular symptoms and non-syphilitic interstitial keratitis. The beneficial response to corticosteroids supports autoimmune pathogenesis. However, the treatment is sometimes difficult as failure to treat hearing loss may cause deafness. Permanent hearing loss usually occurs due to recurrent flares. [50]"}
{"id": "article-143221_52", "title": "Cogan Syndrome -- Deterrence and Patient Education", "content": "The first line of treatment is corticosteroids. Additionally, multiple immunosuppressive drugs have been used. [50] Cochlear implantation is a surgical strategy used in cases with severe sensorineural hearing loss and failure of intensive immunosuppressive regimens. [50] The patients and caregivers should be explained the prognosis, management, and outcome to ensure compliance and the best possible outcome.", "contents": "Cogan Syndrome -- Deterrence and Patient Education. The first line of treatment is corticosteroids. Additionally, multiple immunosuppressive drugs have been used. [50] Cochlear implantation is a surgical strategy used in cases with severe sensorineural hearing loss and failure of intensive immunosuppressive regimens. [50] The patients and caregivers should be explained the prognosis, management, and outcome to ensure compliance and the best possible outcome."}
{"id": "article-143221_53", "title": "Cogan Syndrome -- Enhancing Healthcare Team Outcomes", "content": "The collaboration of the entire healthcare team is mandatory for the management of this condition. The primary care providers should be oriented about this disorder, especially if they present with progressive hearing loss and eye pain. A referral to an ophthalmologist and otolaryngologist for further assessment is mandatory. Screening for other autoimmune diseases should be considered to improve prognosis and outcomes.", "contents": "Cogan Syndrome -- Enhancing Healthcare Team Outcomes. The collaboration of the entire healthcare team is mandatory for the management of this condition. The primary care providers should be oriented about this disorder, especially if they present with progressive hearing loss and eye pain. A referral to an ophthalmologist and otolaryngologist for further assessment is mandatory. Screening for other autoimmune diseases should be considered to improve prognosis and outcomes."}
{"id": "article-143221_54", "title": "Cogan Syndrome -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Cogan Syndrome -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}